Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mind-Body therapies tested to calm anxiety in childhood cancer survivors

NCT ID NCT07380672

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study looks at whether adding hypnosis or relaxation sessions to standard psychological care can lower anxiety in children, teens, and young adults who have finished treatment for pediatric cancer. About 558 participants aged 7 to 25 who are in remission and have anxiety will be split into two groups: one gets standard care alone, the other adds mind-body therapies. The goal is to see if these complementary approaches improve emotional well-being beyond standard support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 558 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: HARMONY KIDS * Patients aged at least 7 and under 15 at the time of inclusion, diagnosed with pediatric cancer, * Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion * Patients receiving follow-up care after pediatric cancer at one of the participating centers, * Patients with anxiety disorders (SCARED-R score ≥ 31) * Patients affiliated with or eligible for social security, * Patients and their parents (or legal guardians) who have received informed consent about the study and co-signed, with the investigator, a consent form to participate in the study. HARMONY AYA * Patients aged at least 15 and no more than 25 years old at the time of inclusion, diagnosed with pediatric cancer before the age of 18, * Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion, * Patients receiving follow-up care after pediatric cancer at one of the participating centers, * Patients with anxiety disorders (HADS-Anxiety score ≥ 8) * Patients affiliated with or eligible for social security, * For adult patients: patients who have received informed information about the study and have co-signed, with the investigator, a consent form to participate in the study, * For minors: patients and their parents (or legal guardians) who have received informed consent about the study and have co-signed, with the investigator, a consent form for participation in the study. Exclusion criteria: For HARMONY-Kids: * Presence of active suicidal ideation and/or need for urgent psychiatric care, * Patient experiencing a cancer relapse, * Refusal to participate, * Pregnant women, women in labor, or breastfeeding mothers, * Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research, * Individuals subject to legal guardianship or conservatorship, or those unable to give informed consent For HARMONY-AYA: * Presence of active suicidal ideation and/or need for urgent psychiatric care, * Patients experiencing a cancer relapse, * Refusal to participate, * Pregnant women, women in labor, or breastfeeding mothers, * Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research, * Adults subject to legal guardianship or conservatorship, or unable to give informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent cancer survivors are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CENTRE HOSPITALIER UNIVERSITAIRE - site NORD

    RECRUITING

    Saint-Etienne, 42055, France

  • Centre Hospitalier Universitaire

    NOT_YET_RECRUITING

    Rouen, 76038, France

  • Centre Hospitalier Universitaire Caen Normandie

    NOT_YET_RECRUITING

    Caen, 14033, France

  • Centre Hospitalier Universitaire Grenoble Alpes

    NOT_YET_RECRUITING

    Grenoble, 38043, France

  • Institut d'Hématologie et d'Oncologie Pédiatrique

    NOT_YET_RECRUITING

    Lyon, 69008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.